New Phenomenex Size Exclusion Columns for Biomolecules

Product News   Jun 07, 2012

 
New Phenomenex Size Exclusion Columns for Biomolecules
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News

Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

READ MORE

Phenomenex Expands Supported Liquid Extraction (SLE) Choices for Cleanup of Diverse Samples

Product News

Phenomenex Inc. announces the addition of a new supported liquid extraction sorbent, using diatomaceous earth, to its offerings for clean sample extraction.

READ MORE

QIAGEN’s QuantiFERON-TB Gold Plus Gains Approval in Japan

Product News

QIAGEN N.V. announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.

READ MORE

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE